GREENWICH LIFESCIENCES INC. - COMMON STOCK

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

13 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

12 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

27 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

22 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

14 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

21 نوفمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire